Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Levosimendan Injection

Approval Number

国药准字H20249838

Company海南合瑞制药股份有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

左西孟旦注射液

Dosage Form

注射剂

Strength

5ml:12.5mg

Drug Type

化学药品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name海南合瑞制药股份有限公司

Company Address

海口国家高新区药谷工业园二期内

Manufacturing Company

Company Name海南合瑞制药股份有限公司

Company Address

海口国家高新区药谷工业园二期内

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

左西孟旦注射液 - NMPA 批准文号 | MedPath